This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers

A Brenn

A Reijerkerk

B Zhang

C Cerutti

DA Ridder

EJ Duh

ES Lippmann

GK Dogbevia

HC Helms

I Loryan

J Greenwood

J Keaney

J Korbelin

JA Ford

M Brkic

M Campbell

MA Lopez-Ramirez

O Huber

P Canning

R Martinelli

RE Vandenbroucke

S Balusu

S Dragoni

Y Hu

Y Molino

YH Chen

Fluids and Barriers of the CNS

English

Abstract After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article

John Greenwood

Margareta Hammarlund-Udenaes

Hazel C. Jones

Alan W. Stitt

Roosmarijn E. Vandenbroucke

Ignacio A. Romero

Matthew Campbell

Gert Fricker

Birger Brodin

Heiko Manninga

Pieter J. Gaillard

Markus Schwaninger

Carl Webster

Krzysztof B. Wicher

Michel Khrestchatisky

Directory of Open Access Journals

Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

Abstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

Crossref

After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article

Greenwood, John

Hammarlund-Udenaes, Margareta

Jones, Hazel C.

Stitt, Alan W.

Vandenbroucke, Roosmarijn E.

Romero, Ignacio A.

Campbell, Matthew

Fricker, Gert

Brodin, Birger

Manninga, Heiko

Gaillard, Pieter J.

Schwaninger, Markus

Webster, Carl

Wicher, Krzysztof B.

Khrestchatisky, Michel

Heidelberger Dokumentenserver

Greenwood et al. Fluids Barriers CNS  (2018) 15:3 https://doi.org/10.1186/s12987-017-0086-xCORRECTIONCorrection to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood1, Margareta Hammarlund‑Udenaes2, Hazel C. Jones3*, Alan W. Stitt4, Roosmarijn E. Vandenbroucke5,6, Ignacio A. Romero7, Matthew Campbell8, Gert Fricker9, Birger Brodin10, Heiko Manninga11, Pieter J. Gaillard12, Markus Schwaninger13, Carl Webster14, Krzysztof B. Wicher15 and Michel Khrestchatisky16,17© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Correction to:  Fluids Barriers CNS (2017) 14:31  https://doi.org/10.1186/s12987‑017‑0079‑9After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article.Firstly, the article’s fifth author had their name spelt incorrectly. Previously included as “Roosmarijn E. Van-denbrouke”, the correct spelling is “Roosmarijn E. Van-denbroucke”. This error was present in the author list and page 3 of the article.Furthermore, author names in the article references had formatting issues. This occurred in cases where “van” is part of the naming structure. In these cases the rest of the last name was included incorrectly as an initial. The references affected are listed below with their corrected author list.Reference #7 should read: Vandenbroucke RE, Dejon-ckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I, et al.Reference #8 should read: Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al.Reference #9 should read: Balusu S, Van Wonterghem E, De Rycke R, Raemdonck K, Stremersch S, Gevaert K, et al.Reference #10 should read: Reijerkerk A, Lopez-Ram-irez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, et al.Reference #22 should read: Loryan I, Sinha V, Mackie C, Van Peer A, Drinkenburg W, Vermeulen A, et al.Open AccessFluids and Barriers of the CNS*Correspondence:  hazelcjones@btinternet.com 3 Gagle Brook House, Chesterton, Bicester OX26 1UF, UKFull list of author information is available at the end of the articlePage 2 of 2Greenwood et al. Fluids Barriers CNS  (2018) 15:3 •  We accept pre-submission inquiries •  Our selector tool helps you to find the most relevant journal•  We provide round the clock customer support •  Convenient online submission•  Thorough peer review•  Inclusion in PubMed and all major indexing services •  Maximum visibility for your researchSubmit your manuscript atwww.biomedcentral.com/submitSubmit your next manuscript to BioMed Central and we will help you at every step:Author details1 Institute of Ophthalmology, University College London, London EC1V 9EL, UK. 2 Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden. 3 Gagle Brook House, Chesterton, Bicester OX26 1UF, UK. 4 Centre for Experimental Medicine, Queen’s University Belfast, Belfast, Northern Ireland, UK. 5 Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. 6 VIB‑UGent Center for Inflammation Research, VIB, Ghent, Belgium. 7 School of Life, Health and Chemical Sciences, Open Uni‑versity, Milton Keynes, UK. 8 Smurfit Institute of Genetics, Lincoln Place Gate, Trinity College Dublin, Dublin 2, Ireland. 9 Institute of Pharmacy and Molecular Biotechnology, Ruprecht‑Karls University, Heidelberg, Germany. 10 Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenha‑gen, Copenhagen, Denmark. 11 NEUWAY Pharma GmbH, Ludwig‑Erhard‑Allee 2, 53175 Bonn, Germany. 12 2‑BBB Medicines BV, Leiden, Netherlands. 13 Insti‑tute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany. 14 Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK. 15 Ossianix Inc., Stevenage, UK. 16 CNRS, NICN, Aix Marseille Univ, Marseille, France. 17 Vect‑Horus, Faculte de Medecine Nord, 51 Boulevard Pierre Dramard, Marseille, France. Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in pub‑lished maps and institutional affiliations.Received: 8 December 2017   Accepted: 12 December 2017Reference 1. Greenwood J, Hammarlund‑Udenaes M, Jones HC, Stitt AW, Vandenb‑roucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gail‑lard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Current research into brain barriers and the delivery of therapeutics for neurologi‑cal diseases: a report on CNS barrier congress London, UK, 2017. Fluids Barriers CNS. 2017;14:31. https://doi.org/10.1186/s12987‑017‑0079‑9.The original article can be found online at https://doi.org/10.1186/s12987‑017‑0079‑9.

This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.Correction in: Fluids and Barriers of the CNS, 2018, 15:3https://doi.org/10.1186/s12987-017-0086-x</p

Vandenbrouke, Roosmarijn E.

Digitala Vetenskapliga Arkivet - Academic Archive On-line

Current research into brain barriers and the delivery of therapeutics for neurological diseases : a report on CNS barrier congress London, UK, 2017

This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.</p

Greenwood, John,

Hammarlund-Udenaes, Margareta,

Jones, Hazel C.,

Stitt, Alan W.,

Vandenbrouke, Roosmarijn E.,

Romero, Ignacio A.,

Campbell, Matthew,

Fricker, Gert,

Brodin, Birger,

Manninga, Heiko,

Gaillard, Pieter J.,

Schwaninger, Markus,

Webster, Carl,

Wicher, Krzysztof B.,

Khrestchatisky, Michel,

Swepub

Current research into brain barriers and the delivery of therapeutics for neurological diseases [Elektronisk resurs] : a report on CNS barrier congress London, UK, 2017

Jones, Hazel C

Stitt, Alan W

Vandenbrouke, Roosmarijn E

Romero, Ignacio A

Gaillard, Pieter J

Wicher, Krzysztof B

Copenhagen University Research Information System

Current research into brain barriers and the delivery of therapeutics for neurological diseases:a report on CNS barrier congress London, UK, 2017

Open Research Online 

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.<p>Correction in: Fluids and Barriers of the CNS, 2018, 15:3</p><p>https://doi.org/10.1186/s12987-017-0086-x</p

Name not available

International audienceAfter publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article

HAL AMU

http://discovery.ucl.ac.uk/10039692/1/s12987-017-0079-9.pdf

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

Directory of Open Access Journals

Crossref

Heidelberger Dokumentenserver

Digitala Vetenskapliga Arkivet - Academic Archive On-line

Swepub

Copenhagen University Research Information System

Open Research Online

Name not available

HAL AMU